These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003. Burger H. Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798 [Abstract] [Full Text] [Related]
29. The role of hormones in the etiology and prevention of endometrial cancer. Gambrell RD. Clin Obstet Gynaecol; 1986 Dec; 13(4):695-723. PubMed ID: 3791826 [Abstract] [Full Text] [Related]
32. The nature of tamoxifen action in the control of female breast cancer. Kodama M, Kodama T. In Vivo; 2001 Dec; 15(4):319-25. PubMed ID: 11695224 [Abstract] [Full Text] [Related]
35. [Prevention and treatment of postmenopausal osteoporosis in women treated for cancer]. Pratili MA, Gest-Laval C. Bull Cancer; 1992 Dec; 79(7):651-7. PubMed ID: 1467591 [Abstract] [Full Text] [Related]
37. The endometrium: effects of estrogen and estrogen-progestogen replacement therapy. Samsioe G. Int J Fertil Menopausal Stud; 1994 Dec; 39 Suppl 2():84-92. PubMed ID: 7874191 [Abstract] [Full Text] [Related]
38. Postmenopausal hormone therapy and risk of breast cancer. Chen FP. Chang Gung Med J; 2009 Dec; 32(2):140-7. PubMed ID: 19403003 [Abstract] [Full Text] [Related]
39. Risks and benefits of long-term treatment with estrogens. Mack TM, Ross RK. Schweiz Med Wochenschr; 1989 Dec 16; 119(50):1811-20. PubMed ID: 2692147 [Abstract] [Full Text] [Related]
40. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M. Br J Fam Plann; 1999 Jul 16; 25(2):69-76. PubMed ID: 10454658 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]